Indian law firm S&R Associates has advised Glenmark Pharmaceuticals on the proposed divestment of 75 percent stake in Glenmark Life Sciences (GLS) for $680 million to Nirma, which was represented by Khaitan & Co.

GLS, which is a manufacturer and supplier of Active Pharmaceutical Ingredients (APIs) to global pharma manufacturers, was advised by Trilegal.

Pursuant to the transaction, Nirma will make a mandatory open offer to all public stakeholders of GLS. Glenmark Pharma will continue to own 7.84 percent of GLS.

The S&R team representing Glenmark Pharma was led by corporate partners Rajat Sethi and Pratichi Mishra, and included antitrust head Simran Dhir, tax partner Sumit Bansal and banking and finance partner Divyanshu Pandey.

The Khaitan team that represented Nirma was led by M&A partners Aashutosh Sampat and Mehul Shah and also included partners Arindam Ghosh (securities), Anisha Chand and Anshuman Sakle (competition), Shailendra Bhandare (IP), Abhiraj Gandhi (real estate) and Deepak Kumar (employment).

The Trilegal team representing GLS was led by the head of the corporate group, Yogesh Singh, along with partners Tejas Adiga and Atul Gupta.

“This deal aligns with our strategic intent of moving up the value chain to become an innovative/brand-led organisation, with continuous focus on our core therapeutic areas of dermatology, respiratory and oncology. It also presents an opportunity for us to strengthen shareholder value through deleveraging and enhancing our overall return profile,” Glenn Saldanha, chairman and managing director of Glenmark Pharma, said in a statement.

GLS will continue to operate as an independent API company under Nirma Limited, Yasir Rawjee, managing director and CEO of GLS, added.



Related Articles

India: AZB, Anagram advise on $530 mln microfinance merger

Mumbai-headquartered law firm AZB & Partners has advised India's AU Small Finance Bank on its 44.11-billion-rupee ($529.8 million) acquisition of peer Fincare Small Finance Bank, which was represented by Anagram Partners.

Shearman, AMT, White & Case, MHM act as Japan’s Benesse goes private for $1.78 bln

by Mari Iwata |

Shearman & Sterling and Anderson Mori & Tomotsune are advising Japanese educational services provider Benesse Holdings on a 270-billion-yen ($1.78 billion) management buyout (MBO) plan proposed by Swedish investment house EQT AB Group, represented by White & Case. Mori Hamada & Matsumoto act for the all stakeholders on this MBO scheme.

Slaughters, Skadden guide $1.8 bln acquisition of Coke Philippines

by Mari Iwata |

Slaughter and May, Villaraza & Angangco, Skadden, Arps, Slate, Meagher & Flom, SyCip Salazar Hernandez & Gatmaitan have advised the buyers on a $1.8 billion acquisition of Coca-Cola Beverages Philippines (CCBPI) from Coca-Cola.